A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
Work
Year: 2022
Type: article
Abstract: Current therapies for HER2-positive breast cancer have limited efficacy in patients with triple-positive breast cancer (TPBC). We conduct a multi-center single-arm phase 2 trial to test the efficacy a... more
Source: Nature Communications
Institutions China Medical University, Dalian Municipal Central Hospital, Dalian Medical University, Affiliated Zhongshan Hospital of Dalian University, Third Affiliated Hospital of Harbin Medical University +14 more
Cites: 31
Cited by: 19
Related to: 10
FWCI: 4.06
Citation percentile (by year/subfield): 84.33
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $4,808